History of primary immunodeficiency diseases

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 6, 2012, Pages 577-587

  Ochsa, Hans D ^a   Hitzigb, Walter H ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Division of Metabolism Childrens' Hospital Zürich   (Switzerland)

Author keywords

Biology of the 19th Century: formed by scientific axioms and experimental evidence; History of primary immunodeficiency diseases; Immunology of the 20th Century: from serendipity to molecular approach

Indexed keywords

ADENOSINE DEAMINASE; ANTHRAX VACCINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; ARSPHENAMINE; DIPHTHERIA VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PENICILLIN G; SULFONAMIDE; T LYMPHOCYTE RECEPTOR; TETANUS TOXIN;

ACTIVE IMMUNIZATION; ADENOSINE DEAMINASE DEFICIENCY; AGAMMAGLOBULINEMIA; ANTHRAX; APOPTOSIS; B LYMPHOCYTE; BLOOD TRANSFUSION; CELL SURFACE; CHRONIC GRANULOMATOUS DISEASE; DIPHTHERIA; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; ELECTROPHORESIS; GENE SEQUENCE; GENOME; GLANZMANN DISEASE; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOCYTOPENIA; MOLECULAR GENETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRISONER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SEZARY CELL; T LYMPHOCYTE; X LINKED AGAMMAGLOBULINEMIA;

HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 84871337373     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32835923a6     Document Type: Review

References (110)

1. Ochs HD, Notarangelo L. Immunodeficiency diseases. In: Kaushansky K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT, editors. Williams Hematology. 8th ed. New York: McGraw Hill Medical; 2010. pp. 1153-1173
2. Schultz W. Ueber eigenartige Halserkrankungen. [Apropos unusual diseases of the pharynx] Dtsch Med Wochenschr 1922; 48:1495-1497
3. Syllaba L, Henner K. Contribution a L'independence de l'athetose double idiopathique et congenitale: atteinte familiale, syndrome dystrophique, signe du reseau vasculaire conjonctival, integrite psychique. Rev Neurol (Paris) 1926; 1:541-562
4. Louis-Bar D. Sur un syndrome progressif comprenant des té langiecstasies capillaires cutané es et conjonctivales symé triques a dispositions naevoide et de truobles cé ré belleux. Conf Neurol (Basel) 1941; 4:32-42
5. Wiskott A. Familiarer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd 1936; 68:212-216
6. Glanzmann E, Riniker P. Essentielle Lymphozytophthise: Ein neues Krankheitsbild der Sa? uglingspathologie. Ann Paediatr 1950; 175:1-32
7. Hitzig WH, Biro Z, Bosch H, Huser HJ. Agammaglobulinemia & alymphocytosis with atrophy of lymphatic tissue. Helv Paediatr Acta 1958; 13:551-585; PMID:13640454
8. Tobler R, Cottier H. Familial lymphopenia with agammaglobulinemia & severe moniliasis: the essential lymphocytophthisis as a special form of early childhood agammaglobulinemia. Helv Paediatr Acta 1958; 13:313-338; PMID: 13610252
9. Hathaway WE, Fulginiti VA, Pierce CW, et al. Graft-vs-host reaction following a single blood transfusion. JAMA 1967; 201:139-144
10. Rosen FS. A brief history of immunodeficiency disease. Immunol Rev 2000; 178:8-12; PMID:11213810
11. Hitzig WH. The discovery of agammaglobulinaemia in 1952. Eur J Pediatr 2003; 162:289-304; PMID:12692709
12. Stiehm ER, Johnston RB Jr. A history of pediatric immunology. Pediatr Res 2005; 57:458-467; PMID:15611343
13. Jenner E. An inquiry into the causes and effects of the variolae vaccinae. London: Sampson-Low; 1798
14. Silverstein AM. The royal experiment on immunity, 1721-1722 In: Silverstein AM, editor. A history of immunology. San Diego: Academic Press; 1989. pp. 24-37
15. Virchow R. Die Cellularpathologie in ihrer Begru?ndung auf physiologische und physiologische Gewebelehre. Hirschwald, Berlin; 1858.
16. Pasteur L. Expé riences relatives aux ge'né rations dites spontané es. C R Acad Sci (Paris) 1860; 50:303-307
17. Koch R. Die Aetiologie der Milzbrandkrankheit, begru? ndet auf die Entwicklungs-Geschichte des Bacillus anthracis. Beitr BioI Pflanzen 1876; 2:277-310
18. Koch R. Die Aetiologie der Tuberculose. Mittheilungen aus dem Kaiserlichen Gesundheitsamt, Berlin 1884. pp 1-88
19. Lo? ffler F. Diphtherie-Bazillus. Mittheilungen aus dem Kaiserlichen Gesundheitsamt, Berlin 1884 pp 451-499
20. Pasteur L. Nouvelle communication sur la rage. C R Acad Sci (Paris) 1886; 103:777-785
21. Roux E, Yersin A. Contribution á l'é tude de la diphthé rie. Ann Inst Pasteur (Paris) 1888; 2:629-661
22. von Behring E, Kitasato S. Ueber das Zustandekommen der Diphtherie-Immunita? t und der Tetanus-Immunita? t bei Tieren. Dtsch med Wschr 1890; 16:1113-1114
23. von Behring E, Ehrlich P. Zur Diphtherieimmunisierungs und Heilungsfrage. Dtsch med Wschr 1894; 20:437-438
24. Kitasato S. Ueber den Tetanuserreger. Dtsch med Wschr 1889; 15:635-636
25. Ehrlich P. On immunity with special reference to cell life. Croonian lecture. Proc R Soc London 1900; 66:424-448
26. Heymann B. Zur Geschichte der Seitenkettentheorie Paul Ehrlichs. Klin Wschr 1928; 7:1257-1260; 1305-1309
27. Buchner H. Ueber die na? here Natur der bacteriento? dtenden Substanz im Blutserum. Zentralbl Bakteriol 1889; 16:561-565
28. Ehrlich P, Sachs H. Ueber die Vielheit der Complemente des Serums. Berl klin Wschr 1902; 39:297-299; 335-298
29. Metschnikoff E. Spongiologische Studien. Z wissensch Zool 1878; 27:115-126
30. Metschnikoff E. Ueber eine Sprosspilzkrankheit der Daphnien. Beitrag zur Lehre u? ber den Kampf der Phagocyten gegen Krankheitserreger. Arch f patholog Anatomie u Physiologie 1884; 96:177-195
31. Ehrlich P. Beitra?ge zur Theorie und Praxis der histologischen Fa?rbung. Inaugural-Dissertation der Medizinischen Fakulta? t der Universita? t Leipzig, vorgelegt am 17 Juni 1878. Leipzig. 1878.
32. Ehrlich P. Modification der von Koch angegebenen Methode der Fa?rbung von Tuberkelbacillen. Dtsch med Wschr 1882; 8:269-270
33. Neumann E. Ueber die Bedeutung des Knochenmarkes fu? r die Blutbildung. Zentralbl Med Wissensch 1868; 6:689.
34. Naegeli O. Ueber rothes Knochenmark und Myeloblasten (Apropos red bone marrow and myeoloblasts). Deutsche Med. Wochensch 1900 26: 285-290
35. Landsteiner K. Ueber Agglutinationserscheinungen normalen menschlichen Blutes. Wien Klin Wochenschr 1901; 14:1132-1134
36. Mulder GJ. Zusammensetzung von Fibrin, Albumin, Leimzucker, Leucin u.s.w. Annalen der Pharmacie 1839; 28:73-82
37. Kossel A. Weitere Beitra?ge zur Chemie des Zellkerns. Zschr physiol Chem 1886; 10:248.
38. Arrhenius SA. Ueber die Dissociation der in Wasser gelo? sten Stoffe. Z Physikal Chemie 1887; 1:631-648
39. Ehrlich P. Die Behandlung der Syphilis mit dem Ehrlich'schen Pra? parat 606. Verh. 82. Vers. Ges dtsch Naturf A? rzt Dtsch Med Wochenschr 1910; 41:1893.
40. Domagk G. Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Dtsch med Wschr 1935; 61:250-253
41. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. Influenzae. Br J Exp Pathol 1929; 10:226-236
42. Tiselius A, Kabat EA. An electrophoretic study of immune sera and purified antibody preparations. J Exp Med 1939; 69:119-131
43. Svedberg T, Pedersen KO. The ultracentrifuge. Oxford: Clarendon Press; 1940.
44. Dettker A, Anduren H. A new time-saving apparatus for paper electrophoresis. Scand J Clin Lab Invest 1954; 6:74-75
45. Schneider G, Wunderly C. Die Papierelektrophorese als Schnellmethode des klinisch-chemischen Laboratoriums. Mo? glichkeiten und Grenzen ihrer Anwendung. Schweiz Med Wochenschr 1952; 82:445-449
46. MRC Working Party on Hypogammaglobulinemia. Hypogammaglobulinemia in the United Kingdom. London: Her Majesty's Stationary Office; 1971.
47. Bruton OC. The discovery of agammaglobulinemia. In: Bergsma D, editor. Immunologic deficiency diseases in man. New York: The National Foundation; 1968. pp. 2-6
48. Bruton OC, Apt L, Gitlin D, Janeway CA. Absence of serum gamma globulins. Am J Dis Child 1952; 84:632-636 (abstract) PMID:12984834.
49. Bruton OC. Agammaglobulinemia. Pediatrics 1952; 9:722-728; PMID: 14929630
50. Donohue WL. Alymphocytosis. Pediatrics 1953; 11:129-139; PMID: 13037432
51. Hitzig WH. Combined cellular and humoral deficiency states. Proc R Soc Med 1968; 61:887-889; PMID:5679006 PMC1902651
52. Good RA. Immunologic deficiency diseases in man. New York: The National Foundation; 1968. p. 473.
53. Fudenberg HH, Good RA, Hitzig W, et al. Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med 1970; 283:656-657; PMID:5456822
54. Griscelli C, Durandy A, Virelizier JL, et al. Selective defect of precursor T cells associated with apparently normal B lymphocytes in severe combined immunodeficiency disease. J Pediatr 1978; 93:404-411; PMID:29085
55. Giblett ER, Anderson JE, Cohen F, et al. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972; 2:1067-1069; PMID:4117384
56. Janeway CA, Craig JM, Davidson M, et al. Hypergammaglobulinemia associated with severe, recurrent and chronic nonspecific infection. Am J Dis Child 1954; 88:388-392
57. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood: the clinical, pathological, and laboratory features of a new syndrome. Am J Dis Child 1959; 97:387-408; PMID:13636694
58. Quie PG, White JG, Holmes B, Good RA. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967; 46:668-679; PMID:6021213 PMC442050
59. Baehner RL, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968; 278:971-976; PMID: 4384563
60. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363:2600-2610; PMID:21190454 PMC3069846
61. Rosen FS, Kevy SV, Merler E, et al. Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases. Pediatrics 1961; 28:182-195; PMID:13743326
62. Mayer L, Kwan SP, Thompson C, et al. Evidence for a defect in 'switch' T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med 1986; 314:409-413; PMID:3080678
63. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligandreceptor pair for thymus-dependent B-cell activation. Immunol Today 1992; 13:431-433; PMID:1282319
64. Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259:990-993; PMID:7679801
65. Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72:291-300; PMID:7678782
66. DiSanto JP, Bonnefoy JY, Gauchat JF, et al. CD40 ligand mutations in Xlinked immunodeficiency with hyper-IgM. Nature 1993; 361:541-543; PMID:8094231
67. Fuleihan R, Ramesh N, Loh R, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A 1993; 90:2170-2173; PMID:7681587 PMC46047
68. Korthauer U, Graf D, Mages HW, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361:539-541; PMID:7679206
69. Ferrari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 2001; 98:12614-12619; PMID:11675497 PMC60102
70. Kutukculer N, Moratto D, Aydinok Y, et al. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 2003; 142:194-196; PMID:12584544
71. Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005; 105:1881-1890; PMID:15358621
72. Seyama K, Kobayashi R, Hasle H, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis 1998; 178:318-324; PMID:9697710
73. Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 2000; 102:565-575; PMID:11007475
74. Imai K, Slupphaug G, Lee WI, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003; 4:1023-1028; PMID:12958596
75. Watson JD, Crick FH. Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 1953; 171:737-738; PMID:13054692
76. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977; 74:5463-5467; PMID:271968 PMC431765
77. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487-491; PMID:2448875
78. Venter JC, AdamsMD, Myers EW, et al. The sequence of the human genome. Science 2001; 291:1304-1351; PMID:11181995.
79. Bolze A, Byun M, McDonald D, et al. Whole-exome-sequencing-based discovery of human FADD deficiency. Am J Hum Genet 2010; 87:873-881; PMID:21109225 PMC2997374
80. Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010; 42:790-793; PMID:20711175 PMC2930028
81. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011; 13:255-262; PMID:21173700
82. Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol 2011; 2:54; PMID:22566844 PMC3342372
83. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32:338-343; PMID:14063511
84. Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol 2012; 129:607-616; PMID:22285280 PMC3294074
85. Wiginton DA, Kaplan DJ, States JC, et al. Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 1986; 25:8234-8244; PMID:3028473
86. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288:669-672; PMID:10784449
87. Aiuti A, Vai S, Mortellaro A, et al. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 2002; 8:423-425; PMID:11984564
88. Conley ME, Dobbs AK, Quintana AM, et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K. J Exp Med 2012; 209:463-470; PMID:22351933 PMC3302225
89. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4:261-268; PMID:12577056
90. van Montfrans JM, Hoepelman AI, Otto S, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012; 129:787-793; e786 PMID:22197273 PMC3294016
91. Lopez-Herrera G, Tampella G, Pan-Hammarstrom Q, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012; 90:986-1001; PMID:22608502 PMC3370280
92. Peron S, Metin A, Gardes P, et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med 2008; 205:2465-2472; PMID:18824584 PMC2571921
93. Etzioni A, Ben-Barak A, Peron S, Durandy A. Ataxia-telangiectasia in twins presenting as autosomal recessive hyper-immunoglobulin M syndrome. Isr Med Assoc J 2007; 9:406-407; PMID:17591387
94. Good RA, Yunis E. Association of autoimmunity, immunodeficiency and aging in man, rabbits, and mice. Fed Proc 1974; 33:2040-2050; PMID:4547388
95. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982; 100:731-737; PMID:7040622
96. Klein C, Welte K. Genetic insights into congenital neutropenia. Clin Rev Allergy Immunol 2010; 38:68-74; PMID:19440858
97. Hanna S, Etzioni A. Leukocyte adhesion deficiencies. Ann N Y Acad Sci 2012; 1250:50-55; PMID:22276660
98. Roos D, Kuijpers TW, Curnutte JT. Chronic granulomatous disease. In: Smith CIE, Ochs HD, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach. 2nd ed. New York: Oxford University Press; 2007. pp. 525-549
99. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 2011; 29:447-491; PMID: 21219179
100. Barandun S, Kistler P, Jeunet F, Isliker H. Intravenous administration of human gamma-globulin. Vox Sang 1962; 7:157-174; PMID: 13864762
101. Janeway CA. The development of clinical uses of immunoglobulins: a review. In: Merler E, editor. Immunoglobulins. Washington D.C.: National Academy of Sciences; 1970. pp. 3-14
102. Abolhassani H, Sadaghiani MS, Aghamohammadi A, et al. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol 2012
103. Hitzig WH, Kenny AB. The role of vitamin B 12 and its transport globulins in the production of antibodies. Clin Exp Immunol 1975; 20:105-111; PMID:128427 PMC1538177
104. Holland SM. Cytokine therapy of mycobacterial infections. Adv Intern Med 2000; 45:431-452; PMID:10635058
105. Gatti RA,Meuwissen HJ, Allen HD, et al. Immunological reconstitution of sexlinked lymphopenic immunological deficiency. Lancet 1968; 2:1366-1369; PMID:4177932
106. Bach FH, Albertini RJ, Joo P, et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968; 2:1364-1366; PMID: 4177931
107. Parkman R, Gelfand EW, Rosen FS, et al. Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med 1975; 292:714-719; PMID:1089883
108. Buckley RH, Fischer A. Bone marrow transplantation for primary immunodeficiency diseases. In: Smith CIE, Ochs HD, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach. 2nd ed. New York: Oxford University Press; 2007. pp. 669-687
109. Boztug K, Schmidt M, Schwarzer A, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 2010; 363:1918-1927; PMID:21067383 PMC3064520
110. Candotti F, Fischer A. Gene therapy. In: Smith CIE, Ochs HD, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach. New York: Oxford University Press; 2007. pp. 688-705